EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Urate‐lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink

Steven J Kiddle, Karolina Andersson Sundell, Shira Perl, Stephen Nolan, Magnus Bjursell

Clinical Cardiology · 2024

DOI: 10.1002/clc.24297 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Steven J Kiddle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Data Science & Advanced Analytics, Data Science & Artificial Intelligence, R&D, AstraZeneca, Cambridge, UK. Hauptthemen laut MEDLINE: Hyperuricemia, Heart Failure, Uric Acid, Gout Suppressants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elevated serum uric acid (sUA) is associated with heart failure (HF). Hypothesis Urate‐lowering therapy (ULT) in HF is associated with lower risk of HF hospitalization (hHF) and mortality.

Methods

Data on patients with HF and gout or hyperuricemia in the Clinical Practice Research Datalink database linked to the Hospital Episode Statistics and the Office for National Statistics in the United Kingdom were analyzed. Risks of hHF and all‐cause mortality or cardiovascular‐related mortality by ULT exposure (ULT initiated within ≤6 months of gout or hyperuricemia diagnosis) were analyzed in a propensity score‐matched cohort using adjusted Cox proportional hazards regression models.

Results

Of 2174 propensity score‐matched pairs, patients were predominantly male, aged >70 years, with mean ± standard deviation sUA 9.3 ± 1.8 (ULT‐exposed) and 9.4 ± 1.9 mg/dL (ULT‐unexposed). At 5 years, ULT‐exposed patients had a 43% lower risk of hHF or all‐cause mortality (adjusted hazard ratio [HR]: 0.57; 95% confidence interval [CI]: 0.51–0.65) and a 19% lower risk of hHF or cardiovascular‐related mortality (adjusted HR: 0.81; 95% CI: 0.71–0.92) versus no ULT exposure.

Conclusion

ULT was associated with reduced risk of adverse clinical outcomes in patients with HF and gout or hyperuricemia over 5 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaHeart FailureUric AcidGout SuppressantsHumansMaleFemaleAgedUnited KingdomRetrospective StudiesRisk FactorsMiddle AgedBiomarkersTreatment OutcomeGoutTime FactorsDatabases, FactualFollow-Up Studies

Stichwörter der Autor:innen

goutheart failurehyperuricemiaurate‐lowering therapy

Substanzen

Uric AcidGout SuppressantsBiomarkers

Autor:innen und Institutionen

  • Data Science & Advanced Analytics, Data Science & Artificial Intelligence, R&D, AstraZeneca, Cambridge, UK.
  • Cardiovascular, Renal and Metabolic (CVRM) Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.
  • Late-stage Development, Clinical, Cardiovascular, Renal and Metabolic (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Late-stage Development, Clinical, Cardiovascular, Renal and Metabolic (CVRM), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Global Medical Affairs, Clinical, Cardiovascular, Renal and Metabolic (CVRM), BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.

Förderung

  • AstraZeneca

Zitieren

APA

Kiddle, S. J., Sundell, K. A., Perl, S., Nolan, S., & Bjursell, M. (2024). Urate‐lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink. Clinical Cardiology. https://doi.org/10.1002/clc.24297

Vancouver

Kiddle SJ, Sundell KA, Perl S, Nolan S, Bjursell M. Urate‐lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink. Clinical Cardiology. 2024. doi:10.1002/clc.24297

BibTeX
@article{Kiddle2024,
  author = {Kiddle, Steven J and Sundell, Karolina Andersson and Perl, Shira and Nolan, Stephen and Bjursell, Magnus},
  title = {Urate‐lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink},
  journal = {Clinical Cardiology},
  year = {2024},
  doi = {10.1002/clc.24297}
}
Kostenlos starten →